Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2008
05/15/2008CA2669207A1 Anti-angiogenic compounds
05/15/2008CA2669185A1 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers
05/15/2008CA2669166A1 Use of an adenosine antagonist
05/15/2008CA2668638A1 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs
05/15/2008CA2668472A1 Improved biological effects of compositions comprising rosmarinic acid
05/15/2008CA2667976A1 Protein-containing agent with increased thermal stability
05/15/2008CA2667155A1 Synthetic peptide amides
05/15/2008CA2667032A1 Hcv ns3 protease inhibitors
05/15/2008CA2667031A1 Hcv ns3 protease inhibitors
05/15/2008CA2665369A1 Human placental collagen compositions, and methods of making and using the same
05/14/2008EP1921133A2 System for processing lipoaspirate cells
05/14/2008EP1921094A2 Method for presenting and removing substances
05/14/2008EP1921089A1 Cytotoxic t-cell epitope peptide and use thereof
05/14/2008EP1921088A2 Peptides and related molecules that bind to tall-1
05/14/2008EP1920780A1 Peptide compounds for the treatment of hyperexcitability disorders
05/14/2008EP1920779A1 Technique for stabilization of yw753 reparation
05/14/2008EP1920061A1 GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES
05/14/2008EP1920056A1 Compositions and methods for treating breast cancer
05/14/2008EP1919954A2 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins
05/14/2008EP1919948A2 Methods and means for controlling the endocytosis and subsequent degradation of a cell surface protein
05/14/2008EP1919947A1 Therapeutically active alpha-msh analogues
05/14/2008EP1919944A2 Modified vegf and pdgf with improved angiogenic properties
05/14/2008EP1919943A2 Melanoma-associated mhc class i associated oligopeptides and the uses thereof
05/14/2008EP1919941A2 Targeting-enhanced activation of galectins
05/14/2008EP1919940A2 Antigenic peptides and their use
05/14/2008EP1919939A2 Tight junction modulating peptide components for enhancing mucosal delivery
05/14/2008EP1919933A2 Gdnf derived peptides
05/14/2008EP1919931A2 Cellular libraries of peptide sequences (clips) and methods of using the same
05/14/2008EP1919513A1 Target vector with activable imaging function
05/14/2008EP1919502A2 Protein compositions for promoting wound healing and skin regeneration
05/14/2008EP1919501A2 Method of treating glaucoma
05/14/2008EP1919500A2 Treatment of leg ulcers using placenta derived collagen biofabric
05/14/2008EP1919499A2 Regulation of tissue factor activity by protein s and tissue factor pathway inhibitor
05/14/2008EP1919498A2 Liquid factor vii composition
05/14/2008EP1919496A2 Abnormal glycosylation in tamm-horsfall protein in interstitial cystitis patient
05/14/2008EP1919495A2 Methods and compositions for treating gastrointestinal radiosensitivity in a subject
05/14/2008EP1919494A2 Non-toxic biofilm inhibitor
05/14/2008EP1919493A2 Use of specific trifluoromethyl ketones for preventing and treating pancreatitis
05/14/2008EP1919492A2 Growth hormone secretagogues
05/14/2008EP1919491A2 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure
05/14/2008EP1919488A1 A composition comprising silver nanoparticles and the use thereof
05/14/2008EP1919481A2 Therapy for neurological diseases
05/14/2008EP1919435A2 Dental composition comprising enzyme
05/14/2008EP1806983B1 Nutritional and/or pharmaceutical preparation for use in prophylaxis and treatment of disturbances in microelements absorption from the alimentary canal
05/14/2008EP1761273B1 Treatment of non alcoholic steatotic hepatitis (nash)
05/14/2008EP1718665A4 Hybrid polypeptides with selectable properties
05/14/2008EP1664332A4 Kinase and phosphatase assays
05/14/2008EP1633882B1 Diagnostics and therapeutics for diseases associated with puromycin-insensitive leucyl-specific aminopeptidase (pils)
05/14/2008EP1633440B1 Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles
05/14/2008EP1529057B1 Biphalin derivatives and their analgesic applications
05/14/2008EP1506009B1 Beta-glucan-based anti-fungal vaccines
05/14/2008EP1461049B1 Use of sulfated glycosaminoglycans for establishing effective labor in women
05/14/2008EP1453531B1 Use of hmgb proteins and nucleic acids that code therefor
05/14/2008EP1418890B1 Propellant-based microparticle formulations
05/14/2008EP1309355B1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties
05/14/2008EP1300158B1 Pharmaceutical compositions for angiogenic therapy
05/14/2008EP1278540B1 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
05/14/2008EP1274728B1 Methods and compositions for the prevention and treatment of anemia
05/14/2008EP1250455B1 Antisense inhibition of ptp1b expression
05/14/2008EP1235934B1 Screening method for candidate drugs
05/14/2008EP1198242B1 Autologous thrombin
05/14/2008EP1136083B1 Hgf for gene therapy of cardiomyopathy
05/14/2008EP1087997B1 Monoclonal antibodies directed against the g3bp protein, and uses
05/14/2008EP1067950B1 Neo-tryptophan
05/14/2008EP1017418B1 Vaccine composition for preventing or treating c hepatitis
05/14/2008EP1009435B1 Method for preventing hiv-1 infection of cd4?+ cells
05/14/2008EP1003552B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
05/14/2008EP0840749B1 The h-y antigen
05/14/2008EP0783313B1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies
05/14/2008EP0772437B9 Compositions for delivery of genetic material
05/14/2008EP0635132B2 Broadly reactive opsonic antibodies that react with common staphylococcal antigens
05/14/2008CN101180401A Isolated dipeptides with ACE inhibitor effect
05/14/2008CN101180315A Il-21 variants
05/14/2008CN101180312A Immunogens from uropathogenic escherichia coli
05/14/2008CN101180267A Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof
05/14/2008CN101180082A Remedy for disease associated with apoptotic degeneration in ocular cell tissue with the use of SIV-PEDF vector
05/14/2008CN101180081A Stabilized polypeptide formulations
05/14/2008CN101180074A Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor(tfpi)
05/14/2008CN101180073A Insulins combinations
05/14/2008CN101180072A Methods of using death receptor agonists and egfr inhibitors
05/14/2008CN101180071A Composition for enzyme inhibition
05/14/2008CN101180070A Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions
05/14/2008CN101180061A Compounds, and compositions containing the compounds, and method for treatment of metastatic melanoma and other cancers
05/14/2008CN101180044A Combination of egf/ghrp-6 for neuroregeneration of central nervous system
05/14/2008CN101179954A Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses
05/14/2008CN101179935A Revascularization of ischemic retinal tissue and screening method therefor
05/14/2008CN101177700A Methods and means for producing proteins with predetermined post-translational modifications
05/14/2008CN101177681A Rhabdophis tigrina snake uncoupling protein gene-SB and uses thereof
05/14/2008CN101177455A Modified transferrin fusion proteins
05/14/2008CN101177454A IL-18 mutant polypeptide as well as preparation and usage
05/14/2008CN101177453A Recombined chimeric antibody against human tumor necrosis factor alpha
05/14/2008CN101177450A Short-peptide triggering male penis erection and improving female libido
05/14/2008CN101177449A Furca polypeptide, drug composition and use thereof
05/14/2008CN101176786A Method and composition for increasing insulin sensibility
05/14/2008CN101176785A Regrouping bi-functional leech essence oral preparation and preparation method thereof
05/14/2008CN101176784A Application of compounds methionine enkephalin for preparing medicine for curing blood medulla hematopoietic system cancer
05/14/2008CN100387718C Proteinase K resistant surface protein of neisseria meningitidis
05/14/2008CN100387713C Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same
05/14/2008CN100387710C Therapy for primary and metastatic cancers
05/14/2008CN100387708C Method for high level expression of active lymphotoxin-betareceptor immunoglobulin and purification method therefor
1 ... 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 ... 3163